Wealth Alliance’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$447K Buy
844
+12
+1% +$5.54K 0.04% 340
2026
Q1
$400K Buy
832
+64
+8% +$32.8K 0.04% 351
2025
Q4
$431K Sell
768
-145
-16% -$82.3K 0.04% 340
2025
Q3
$469K Sell
913
-79
-8% -$34.5K 0.05% 316
2025
Q2
$311K Buy
992
+51
+5% +$15.3K 0.03% 395
2025
Q1
$287K Buy
941
+76
+9% +$25.6K 0.03% 398
2024
Q4
$287K Sell
865
-91
-10% -$30.9K 0.03% 397
2024
Q3
$319K Sell
956
-14
-1% -$5.32K 0.04% 384
2024
Q2
$399K Buy
970
+27
+3% +$10.7K 0.05% 305
2024
Q1
$381K Sell
943
-110
-10% -$38.7K 0.05% 333
2023
Q4
$323K Buy
1,053
+95
+10% +$25.6K 0.05% 364
2023
Q3
$232K Sell
958
-5
-0.5% -$1.28K 0.04% 427
2023
Q2
$231K Buy
+963
New +$200K 0.03% 446

Other funds holding MEDP

Wealth Alliance's MEDP Position: Q2 2026 in Review

Wealth Alliance increased its Medpace (MEDP) stake by 1.4% in Q2 2026, buying an estimated $5.54K and bringing the position to 844 shares worth $447K. The position accounts for 0.04% of the portfolio, ranked #340.

Wealth Alliance first reported a position in MEDP in Q2 2023 and has held it in 13 quarters since. The position peaked at $469K in Q3 2025. 698 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Wealth Alliance held 844 shares of Medpace worth $447K as of Q2 2026.
  • Wealth Alliance bought 12 Medpace shares in Q2 2026, an estimated $5.54K.
  • Medpace made up 0.04% of Wealth Alliance's portfolio in Q2 2026, its #340 holding.
  • Wealth Alliance first reported a position in Medpace in Q2 2023 and has held it in 13 quarters since.
  • Wealth Alliance's Medpace position peaked at $469K in Q3 2025.
  • 698 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Wealth Alliance's 13F filing for Q2 2026, filed 11 Aug 2026.